Press & Announcements
Press & Announcements
The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120 low- and middle-income countries starting in 2027, under a new partnership announced today between Dr. Reddy’s Laboratories and Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI.
Read more
Strategic three-year collaboration aims to improve public health outcomes through government-led digitization of campaigns and financial systems
Read more
MedAccess, Unitaid, and CHAI announce a new volume guarantee agreement between MedAccess and Synergy Gases Ltd (Synergy) to expand access to affordable oxygen for medical use across sub-Saharan Africa.
Read more
The second edition of CHAI’s HIV Market Impact Memo highlights the ongoing impact of cuts to HIV services across low- and middle-income countries.
Read more
A new 2025 Assistive Products Market Report by ATscale and CHAI, projects the global assistive technology market will double in nine years
Read moreCHAI in the News
Children living with HIV ‘not getting treatment needed’ as aid cuts hit services
Global health groups push to make cheap generic versions of an HIV prevention drug sold by Gilead
CHAI CEO named to Devex Power 50
New York Times: Philanthropies strike a promising deal to turn back HIV
The Independent: Inside the battle to end the Aids pandemic in the face of Trump’s cuts
Devex: ‘We’re not seeing a rebound’: New data shows HIV services not recovering
Devex: CHAI CEO urges fresh vision for global health amid aid cuts
New York Times: The global threat of antibiotic resistance
BBC: Three million child deaths linked to drug resistance, study shows
Al Jazeera: Why is the world suffering from a penicillin shortage?
Grist: How do you take clean AC mainstream? This global health organization has some ideas.
Science: Plans to expand African vaccine production face steep hurdles
For press inquiries contact:
Corina Milic, Director of Communications
press@clintonhealthaccess.org